Individuals affected by hypoxia experience a variety of immune-associated sickness symptoms including malaise, fatigue, lethargy and loss of interest in the physical and social environment. Recently, we demonstrated that the interleukin (IL)-1b arm of the neuroimmune system was critical to the sickness symptoms caused by hypoxia, and that IL-1 receptor antagonist (IL-1RA), IL-1b's endogenous inhibitor, was critical to promoting sickness recovery. Here, we report that leptin is key to recovery from hypoxia because it dramatically augmented IL-1RA production in mice. We found that hypoxia increased leptin in white adipose tissue (WAT) which in turn, caused a marked rise in serum IL-1RA. Interestingly, in-vitro, leptin was a more potent inducer of IL-RA, in macrophages, than hypoxia. In leptin receptor defective (db/ db) and leptin deficient (ob/ob) mice, sickness recovery from hypoxia was delayed 3-fold. Importantly, in ob/ob mice, leptin administration completely reversed this delayed recovery and induced a marked increase in serum IL-1RA. Finally, leptin administration to normal mice reduced hypoxia recovery time by 1/3 and dramatically increased WAT and serum IL-1RA. Leptin did not alter recovery from hypoxia in IL-1RA knock out mice. These results show that by enhancing IL-1RA production leptin promoted sickness recovery from hypoxia.
Introduction
As a term, hypoxia, in its most encompassing, indicates a diminished availability of oxygen. Systemic hypoxia occurs in a variety of conditions, diseases and accidents often precipitated by dysfunctional respiration (Braunwald, 2008) , but loss of blood-based oxygen carrying capacity, reduced oxygen transportation from capillaries to tissue (Simon et al., 2006) and environmental oxygen loss (Basnyat and Murdoch, 2003) are also common precipitants. In the medical setting, hypoxia is often a component of congestive heart failure (Quaranta et al., 1997), heart attack (Burke and Virmani, 2007) and infectious and non-infectious lung diseases (Browne and Pitchumoni, 2006; Cottin et al., 1998) . Additionally, hospital inpatient hypoxia accounts for up to 41% of calls for emergency response teams (Jones et al., 2006) . Outside the primary care setting, pulmonary disease-associated hypoxia often significantly impacts well-being, as the acute and overt consequences of labored breathing, dyspnea, and dizziness significantly suppresses the performance of activities of daily living (Kelly et al., 2007) . Interestingly, hypoxia can clinically mimic other conditions like acute alcoholism due to the symptom constellation of impaired judgment, motor in-coordination and confusion (Kress and Hall, 2008) . Severe hypoxia impacts higher brain functions within minutes resulting in loss of purposeful behavior and consciousness (Pena and Ramirez, 2005) . Less dramatic hypoxia precipitates a variety of symptoms that elicit the subjective feelings of sickness including malaise, fatigue, lethargy and loss of interest in the physical and social environment. These symptoms are especially common in those suffering from acute mountain sickness (Clarke, 2006) and can be experienced during both the hypoxic episode and after return of the individual to normal oxygenation (ViruesOrtega et al., 2006) . In normal subjects, mixed venous oxygen saturation (SmVO2) is approximately 75% (Kress and Hall, 2008) with hypoxia-associated sickness symptoms usually manifesting at an SmVO2of 70% (Kelly et al., 2007) .
Given the sickness symptoms induced by hypoxia, it is not surprising that in the last 10 years, the significance of hypoxia has extended beyond its somewhat straightforward metabolic bearing on highly oxygen reliant organs like heart (Fisher and Burggren, 2007; Ostadal et al., 1999) and brain (Pena and Ramirez, 2005) . Hypoxia is now recognized as a powerful innate immune activator (Rius et al., 2008; Johnson et al., 2007; Kozak et al., 2006; Hu et al., 2005) that causes the elaboration of pro-inflammatory cytokines (Kozak et al., 2006; Basu et al., 2005; Gehrmann et al., 1992; Lazovic et al., 2005) , which, in turn, influence the neuroimmune system (Johnson et al., 2007; Johnson et al., 2008; Dantzer, 2004; Dantzer et al., 2001) . In C3H/HeN mice, exposure to 5% oxygen for 60 min causes a rapid increase in plasma tumor necrosis factor (TNF)-a 
